Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ANTAGEN BIOSCIENCES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-01 to 2022-08-31
Current total value of award: $600000
Description: EO14042 SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES